Cereno Scientific and OCT signs contract for the conduct of a phase II study in patients undergoing knee replacement

The two companies have now reached a definitive agreement and set out the framework for the planned phase II study.

Read more



BIO-Europe 2018 2018-11-05

Biotech and money showcase 2018 2018-11-13

Jefferies 2018 London Healthcare Conference 2018-11-14

Interim report Q3 2018-11-15

Nordic-American Life Science Conference, New York 2018-11-29

Year-end report 2018 2019-02-22

More about us...

Subscribe for corporate news

Follow us on LinkedIn

Follow us on Twitter

Privacy policy

We are proud supporters of World Thrombosis Day. Read more